A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TD / testosterone deficiency

[Related PubMed/MEDLINE]
Total Number of Papers: 58
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TD  (>> Co-occurring Abbreviation)
Long Form:   testosterone deficiency
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency. RCTs, TRT
2019 Analysis of cardiovascular risk factors associated with serum testosterone levels according to the US 2011-2012 National Health and Nutrition Examination Survey. BMI, HDL-C
2019 Cyclophilin D participates in the inhibitory effect of high-fat diet on the expression of steroidogenic acute regulatory protein. CypD, HFD, PA, StAR
2019 Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. TTh
2019 Guideline of guidelines: testosterone therapy for testosterone deficiency. TTh
2019 Peyronie's disease and testosterone deficiency: Is there a link? PD
2019 Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation. TRT, TT
2019 Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study. ABPM, BP, PK, SCTE-AI, TE
2019 Safety of testosterone therapy in men with prostate cancer. PCa, TTh
10  2019 Testosterone Deficiency: A Review and Comparison of Current Guidelines. TTh
11  2019 The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a cross-sectional study. BMI, BPH, PSA, TT
12  2018 Androgen Deficiency in Aging Male Questionnaire for the Clinical Detection of Testosterone Deficiency in a Population of Black Sub-Saharan African Men with Type 2 Diabetes Mellitus: Is it a Reliable Tool? ADAM, NPV, PPV, T2DM
13  2018 Daily subcutaneous testosterone for management of testosterone deficiency. DHEAS, DHT, DST, FSH, hCG, LH, PSA, SHBG
14  2018 Erectile dysfunction and testosterone deficiency as cardiovascular risk factors? ---
15  2018 Hepatocyte Nuclear Factor-4alpha P2 Promoter Variants Are Associated With the Risk of Metabolic Syndrome and Testosterone Deficiency in Aging Taiwanese Men. HNF4A, MetS, SNPs
16  2018 Testosterone in renal transplant patients: effect on body composition and clinical parameters. AMS, AR, eGFR, Hb, TT
17  2018 The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. CV, MACE, TTh
18  2017 British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. ---
19  2017 Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery. NTI
20  2017 Testosterone deficiency in adults and corresponding treatment patterns across the globe. TRT, TT
21  2017 The Graham Jackson Memorial Lecture ISSM 2016-"The Man Who Knew Too Much": Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular Disease. CV, ED, ISSM
22  2016 Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. AOH, TRT
23  2016 Age, Body Mass Index, and Frequency of Sexual Activity are Independent Predictors of Testosterone Deficiency in Men With Erectile Dysfunction. BMI, cFT, ED, TT
24  2016 Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM2015). ICSM, LoEs
25  2016 Endocrinology Update: Testicular Hypogonadism. ---
26  2016 Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis. CT, PRISMA, RT, TGCC
27  2015 Diagnosis and management of testosterone deficiency. TST
28  2015 Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS). MetS, OGD, TDMetS
29  2015 International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. CV
30  2015 Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. ---
31  2015 The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. CVD, MetS
32  2015 The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. ISSM
33  2014 Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. TRT
34  2014 Adverse health effects of testosterone deficiency (TD) in men. ED, IR, T2DM
35  2014 Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. LH, TTh
36  2014 Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. MetS, TC
37  2014 Outcomes of testosterone therapy in men with testosterone deficiency (TD): part II. ---
38  2014 Testosterone deficiency: a determinant of aortic stiffness in men. TT
39  2014 Testosterone deficiency: myth, facts, and controversy. ---
40  2014 Testosterone promotes glucose intolerance, lipid disorder and oxidative stress in type 1 diabetic rats. FBG, T1DM, T2DM
41  2013 Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study. BFM, BMD, DEXA, LBM, TU
42  2013 Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. PSA, TT, TU
43  2013 Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population. cFT, EqD, FT, RIA, SHBG
44  2013 The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. CVD, DM, ORFs, RR
45  2013 The evaluation and management of testosterone deficiency: the new frontier in urology and men's health. TTh
46  2013 [Clinical and biochemical diagnosis of androgenic deficit in adult men]. BioT, TT
47  2012 Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy. FM, FT, LM, TT, TTh
48  2012 Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily. ---
49  2011 Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease. ---
50  2011 Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. BMI, FT, PSA, SHBG, TRiUS, TRT, TT
51  2011 Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction. ED, IR, MetS
52  2011 Testosterone deficiency as a risk factor for cardiovascular disease. ---
53  2011 Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. TGCC
54  2011 Testosterone deficiency. ---
55  2010 Endocrine aspects of male sexual dysfunctions. ---
56  2010 Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. TT
57  2010 Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. ED, FT, TTh
58  2009 Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship. FT, PD, TT